Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Factors affecting successful mobilization with plerixafor: an Italian prospective survey in 215 patients with multiple myeloma and lymphoma.
Lanza F, Lemoli RM, Olivieri A, Laszlo D, Martino M, Specchia G, Pavone V, Imola M, Pasini A, Milone G, Scortechini I, Todisco E, Guggiari E, Cascavilla N, Martinelli G, Rambaldi A, Bosi A. Lanza F, et al. Among authors: guggiari e. Transfusion. 2014 Feb;54(2):331-9. doi: 10.1111/trf.12265. Epub 2013 Jun 19. Transfusion. 2014. PMID: 23781769
Plerixafor and G-CSF for PBSC mobilization in patients with lymphoma who failed previous attempts with G-CSF and chemotherapy: a REL (Rete Ematologica Lombarda) experience.
Arcaini L, Laszlo D, Rizzi S, Balzarotti M, Antoniazzi F, Zilioli VR, Guggiari E, Farina L, Todisco E, Bonfichi M, Alamos SM, Rossi G, Martinelli G, Morra E. Arcaini L, et al. Among authors: guggiari e. Leuk Res. 2011 Jun;35(6):712-4. doi: 10.1016/j.leukres.2010.12.036. Epub 2011 Jan 26. Leuk Res. 2011. PMID: 21276613 Clinical Trial.
The Italian Mastocytosis Registry: 6-year experience from a hospital-based registry.
Merante S, Ferretti VV, Elena C, Brazzelli V, Zanotti R, Neri I, Magliacane D, Belloni Fortina A, Ingeborg F, Pastorello EA, Pieri L, Papayannidis C, Mauro M, Grifoni F, Minelli R, Guggiari E, Difonzo E, Bocchia M, Caroppo F, Di Nuzzo S, Elli EM, Rondoni M, Ciccocioppo R, Di Stefano M, Bossi G, Boveri E, Bonadonna P, Giona F, Valent P, Triggiani M. Merante S, et al. Among authors: guggiari e. Future Oncol. 2018 Nov;14(26):2713-2723. doi: 10.2217/fon-2018-0291. Epub 2018 Sep 12. Future Oncol. 2018. PMID: 30207489
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors.
Peccatori J, Forcina A, Clerici D, Crocchiolo R, Vago L, Stanghellini MT, Noviello M, Messina C, Crotta A, Assanelli A, Marktel S, Olek S, Mastaglio S, Giglio F, Crucitti L, Lorusso A, Guggiari E, Lunghi F, Carrabba M, Tassara M, Battaglia M, Ferraro A, Carbone MR, Oliveira G, Roncarolo MG, Rossini S, Bernardi M, Corti C, Marcatti M, Patriarca F, Zecca M, Locatelli F, Bordignon C, Fleischhauer K, Bondanza A, Bonini C, Ciceri F. Peccatori J, et al. Among authors: guggiari e. Leukemia. 2015 Feb;29(2):396-405. doi: 10.1038/leu.2014.180. Epub 2014 Jun 4. Leukemia. 2015. PMID: 24897508 Clinical Trial.
Treosulfan based reduced toxicity conditioning followed by allogeneic stem cell transplantation in patients with myelofibrosis.
Claudiani S, Marktel S, Piemontese S, Assanelli A, Lupo-Stanghellini MT, Carrabba M, Guggiari E, Giglio F, De Freitas T, Marcatti M, Bernardi M, Corti C, Peccatori J, Lunghi F, Ciceri F. Claudiani S, et al. Among authors: guggiari e. Hematol Oncol. 2016 Sep;34(3):154-60. doi: 10.1002/hon.2183. Epub 2014 Dec 3. Hematol Oncol. 2016. PMID: 25469485
Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantation.
Lorentino F, Xue E, Mastaglio S, Giglio F, Clerici D, Farina F, Piemontese S, Bruno A, Lazzari L, Ruggeri A, Guggiari E, Lunghi F, Assanelli AA, Marktel S, Marcatti M, Carrabba MG, Bernardi M, Corti C, Peccatori J, Ciceri F, Greco R, Lupo-Stanghellini MT. Lorentino F, et al. Among authors: guggiari e. Blood Adv. 2022 May 24;6(10):3053-3057. doi: 10.1182/bloodadvances.2021006213. Blood Adv. 2022. PMID: 35078219 Free PMC article. No abstract available.
Immune Reconstitution-Based Score for Risk Stratification of Chronic Graft-Versus-Host Disease Patients.
Serpenti F, Lorentino F, Marktel S, Milani R, Messina C, Greco R, Girlanda S, Clerici D, Giglio F, Liberatore C, Farina F, Mastaglio S, Piemontese S, Guggiari E, Lunghi F, Marcatti M, Carrabba MG, Bernardi M, Bonini C, Assanelli A, Corti C, Peccatori J, Ciceri F, Lupo-Stanghellini MT. Serpenti F, et al. Among authors: guggiari e. Front Oncol. 2021 Jul 22;11:705568. doi: 10.3389/fonc.2021.705568. eCollection 2021. Front Oncol. 2021. PMID: 34367991 Free PMC article.
Bone marrow mammaglobin expression as a marker of graft-versus-tumor effect after reduced-intensity allografting for advanced breast cancer.
Bregni M, Fleischhauer K, Bernardi M, Pescarollo A, Guggiari E, Lunghi F, Deola S, Scaramuzza S, Re F, Setola E, Monari M, Mazzi B, Servida P, Corradini P, Peccatori J. Bregni M, et al. Among authors: guggiari e. Bone Marrow Transplant. 2006 Feb;37(3):311-5. doi: 10.1038/sj.bmt.1705248. Bone Marrow Transplant. 2006. PMID: 16400340
20 results